Bachem

Bachem is a leading global specialist in the development and manufacturing of peptides and oligonucleotides, serving the pharmaceutical and biotechnology industries with innovative solutions for drug development and production. Headquartered in Bubendorf, Switzerland, the company has established itself as a trusted partner for both research-grade a... nd commercial-scale production of complex active pharmaceutical ingredients, providing comprehensive services that span from early-stage research and development through clinical trials to full-scale commercial manufacturing. Bachem's expertise encompasses a wide range of peptide technologies, including solid-phase and liquid-phase peptide synthesis, as well as advanced oligonucleotide manufacturing capabilities that support the growing field of genetic medicines and RNA therapeutics. The company operates state-of-the-art production facilities across multiple continents, maintaining rigorous quality standards and regulatory compliance to meet the stringent requirements of global pharmaceutical markets. Bachem serves a diverse customer base ranging from small biotech startups to major multinational pharmaceutical companies, supporting the development of innovative therapeutics across various disease areas including oncology, metabolic disorders, cardiovascular diseases, and rare genetic conditions. With decades of experience and deep scientific knowledge, Bachem combines cutting-edge technology platforms with flexible manufacturing capabilities and regulatory expertise to accelerate the journey from peptide discovery to marketed drugs. The company's commitment to quality, reliability, and customer partnership has positioned it as an essential link in the pharmaceutical supply chain, contributing to the advancement of peptide-based and oligonucleotide-based medicines that improve patient outcomes worldwide.Read More